Department of Health Services Management and Policy, College of Public Health, East Tennessee State University, S. Dossett Drive, Lamb Hall, P.O. Box 70264, Johnson City, TN 37614, USA.
Division of Cardiology, James H. Quillen College of Medicine, East Tennessee State University, 1123 Waterbrooke Lane, Johnson City, TN 37604, USA.
Atherosclerosis. 2014 Oct;236(2):338-50. doi: 10.1016/j.atherosclerosis.2014.07.022. Epub 2014 Aug 1.
To perform systematic review of the effects of screening for coronary artery calcium (CAC), a subclinical marker of coronary artery disease (CAD), on behavioral or lifestyle modification, risk perception, and medication adherence.
We searched through CINAHL, PsychInfo, Web of Science, Cochrane Central Register of Control Trials, and PubMed (Medline) for studies on the effects of CAC screening in asymptomatic individuals across three major domains: behavioral modification, risk perception for CAD, and medication adherence. We extracted data from the retrieved studies, assessed and synthesized the information.
Of the 15 retrieved studies, three were randomized control trials and 12 were observational studies. CAC score was ascertained either as total score, quartiles, or standardized Agatston's ordinal scale. While all the 15 studies involved issues related to behavioral and medication adherence, four involved risk perception of CAD. Although no standardized approach was used in these studies, CAC screening enhanced medication adherence in 13 of the 15 studies, while the others were mixed.
CAC screening improved medication adherence and could likely motivated individuals for beneficial behavioral or lifestyle changes to improve CAD. The mixed results suggest the need for further research because screening for subclinical atherosclerosis has significant implications for early detection and prevention of future cardiovascular events by aggressive risk factors modification.
系统评价冠状动脉钙(CAC)筛查对无症状个体的行为或生活方式改变、风险感知和药物依从性的影响,CAC 是冠状动脉疾病(CAD)的一种亚临床标志物。
我们在 CINAHL、PsychInfo、Web of Science、Cochrane 对照试验中心注册库和 PubMed(Medline)中搜索了关于 CAC 筛查在三个主要领域对无症状个体的影响的研究:行为改变、CAD 风险感知和药物依从性。我们从检索到的研究中提取数据,评估并综合信息。
在检索到的 15 项研究中,有 3 项为随机对照试验,12 项为观察性研究。CAC 评分确定为总评分、四分位数或标准化的 Agatston 等级量表。虽然所有 15 项研究都涉及与行为和药物依从性相关的问题,但有 4 项研究涉及 CAD 的风险感知。虽然这些研究没有使用标准化的方法,但 CAC 筛查在 15 项研究中的 13 项中提高了药物依从性,而其他研究则是混合的。
CAC 筛查提高了药物依从性,并可能促使个体进行有益的行为或生活方式改变,以改善 CAD。混合的结果表明需要进一步研究,因为对亚临床动脉粥样硬化的筛查通过积极的危险因素改变对未来心血管事件的早期检测和预防具有重要意义。